KMT2C and breast carcinoma: According to cBioportal, KMT2C is frequently mutated in a variety of cancer types such as breast cancer (~ 12%), melanoma (~ 45%), colon cancer (~ 14%) and hepatocellular carcinoma (50%) (30).